Skip to content
Global markets · Independent coverage Follow a hub and receive new coverage by email.

NASDAQ:MESO

Mesoblast (MESO) stock drops 11% as traders digest insider buy and Ryoncil sales backdrop

Mesoblast Ltd’s shares on the U.S. market dropped roughly 11% Monday, sliding to $18.64 in afternoon trading after hitting $20.14 earlier. The Australian biotech’s stock has seen sharp swings since it started highlighting early…

3 min read
NASDAQ:MESO

Company hubNASDAQ:MESO

Mesoblast (MESO) (MESO) Stock News & Analysis

Follow the latest Mesoblast (MESO) (MESO) company news, earnings coverage and investor analysis from TechStock².

Save this hub to your TS2 Signalbook account.
Latest update
Articles in this hub
2
Last 30 days
0

What investors are watching

  • Earnings, guidance and financial performance
  • Valuation, trading activity and market sentiment
  • Strategy, catalysts and company-specific risks

All coverage

NASDAQ:MESO

2 articles